BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

C4X Discovery

C4X Discovery logo

Founded
2008
Patents
5
Publications
8

Technologies

AI Companies (Drug Discovery)

C4X Discovery has a state-of-the-art suite of proprietary technologies across the drug discovery process. The company's innovative DNA-based target identification platform (Taxonomy3(R)) utilises human genetic datasets to identify novel patient-specific targets leading to greater discovery productivity and increased probability of clinical success. This is complemented by C4XD's novel drug design platform which comprises two innovative chemistry technologies, Conformetrix and Molplex, that combine 4D molecular shape analyses (based on experimental data) with best-in-class computational chemistry.

C4X Discovery is advancing its in-house pipeline that is primarily focused on the high value therapeutic areas of inflammation, neurodegeneration and cancer (including immuno-oncology) with a number of new drug candidates identified and further progress made towards the pre-clinical licensing discussions. In selecting new targets and executing new drug discovery programmes, C4X Discovery focuses on high-value disease areas that are the subject of significant licensing activity and will continue to also maximise value from opportunistic areas such as addiction and diabetes.

drug discovery small molecules


Posts Mentioning This Company

The Increasing Potential of Virtual Reality in Drug Design

  
Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological opportunity, which increasingly grabs attention among scientists at biotech startups, and larger pharmaceutical organizations. 
SHARE